Cargando…
Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis
Oral cancer (OC) is an uncommon malignancy in Western countries, being one of the most common cancers in some high-risk areas of the world. It is a largely preventable cancer, since most of the different risk factors identified, such as tobacco use, alcohol consumption, and betel nut chewing, are be...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764090/ https://www.ncbi.nlm.nih.gov/pubmed/33302498 http://dx.doi.org/10.3390/ijerph17249160 |
_version_ | 1783628174043643904 |
---|---|
author | Abati, Silvio Bramati, Chiara Bondi, Stefano Lissoni, Alessandra Trimarchi, Matteo |
author_facet | Abati, Silvio Bramati, Chiara Bondi, Stefano Lissoni, Alessandra Trimarchi, Matteo |
author_sort | Abati, Silvio |
collection | PubMed |
description | Oral cancer (OC) is an uncommon malignancy in Western countries, being one of the most common cancers in some high-risk areas of the world. It is a largely preventable cancer, since most of the different risk factors identified, such as tobacco use, alcohol consumption, and betel nut chewing, are behaviors that increase the likelihood of the disease. Given its high mortality, early diagnosis is of utmost importance. Prevention and the anticipation of diagnosis begin with identification of potentially malignant lesions of the oral mucosa and with local conditions promoting chronic inflammation. Therefore, every lesion must be recognized promptly and treated adequately. The clinical recognition and evaluation of oral mucosal lesions can detect up to 99% of oral cancers/premalignancies. As stated by the World Health Organization, any suspicious lesion that does not subside within two weeks from detection and removal of local causes of irritation must be biopsied. Surgical biopsy remains the gold standard for diagnosis of oral cancer. Adjunctive tools have been developed and studied to help clinicians in the diagnostic pathway, such as toluidine blue vital staining and autofluorescence imaging. In the near future other methods, i.e., identification of salivary markers of progression may help in reducing mortality due to oral cancer. |
format | Online Article Text |
id | pubmed-7764090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77640902020-12-27 Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis Abati, Silvio Bramati, Chiara Bondi, Stefano Lissoni, Alessandra Trimarchi, Matteo Int J Environ Res Public Health Review Oral cancer (OC) is an uncommon malignancy in Western countries, being one of the most common cancers in some high-risk areas of the world. It is a largely preventable cancer, since most of the different risk factors identified, such as tobacco use, alcohol consumption, and betel nut chewing, are behaviors that increase the likelihood of the disease. Given its high mortality, early diagnosis is of utmost importance. Prevention and the anticipation of diagnosis begin with identification of potentially malignant lesions of the oral mucosa and with local conditions promoting chronic inflammation. Therefore, every lesion must be recognized promptly and treated adequately. The clinical recognition and evaluation of oral mucosal lesions can detect up to 99% of oral cancers/premalignancies. As stated by the World Health Organization, any suspicious lesion that does not subside within two weeks from detection and removal of local causes of irritation must be biopsied. Surgical biopsy remains the gold standard for diagnosis of oral cancer. Adjunctive tools have been developed and studied to help clinicians in the diagnostic pathway, such as toluidine blue vital staining and autofluorescence imaging. In the near future other methods, i.e., identification of salivary markers of progression may help in reducing mortality due to oral cancer. MDPI 2020-12-08 2020-12 /pmc/articles/PMC7764090/ /pubmed/33302498 http://dx.doi.org/10.3390/ijerph17249160 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Abati, Silvio Bramati, Chiara Bondi, Stefano Lissoni, Alessandra Trimarchi, Matteo Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis |
title | Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis |
title_full | Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis |
title_fullStr | Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis |
title_full_unstemmed | Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis |
title_short | Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis |
title_sort | oral cancer and precancer: a narrative review on the relevance of early diagnosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764090/ https://www.ncbi.nlm.nih.gov/pubmed/33302498 http://dx.doi.org/10.3390/ijerph17249160 |
work_keys_str_mv | AT abatisilvio oralcancerandprecanceranarrativereviewontherelevanceofearlydiagnosis AT bramatichiara oralcancerandprecanceranarrativereviewontherelevanceofearlydiagnosis AT bondistefano oralcancerandprecanceranarrativereviewontherelevanceofearlydiagnosis AT lissonialessandra oralcancerandprecanceranarrativereviewontherelevanceofearlydiagnosis AT trimarchimatteo oralcancerandprecanceranarrativereviewontherelevanceofearlydiagnosis |